FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4252006237> ?p ?o ?g. }

• W4252006237 endingPage "1347" @default.
• W4252006237 startingPage "1347" @default.
• W4252006237 abstract "0016 A growing body of evidence suggests that oxidative modification of LDL-cholesterol is important in the early development of atherosclerotic lesions. Although past observational epidemiologic evidence suggests CHD benefit for long term vitamin E supplement use, two recent large secondary prevention trials have not found a lower risk of CVD among patients randomized to vitamin E. Data comparing the benefits of vitmain E between populations with and without prior CVD have not been adequately explored. We examined prospectively the association between vitamin E supplements (>100 IU/day for 2 or more years) and risk of coronary heart disease among 38,884 U.S. male health professionals, 40 to 75 years of age at baseline (1986) and who were free of diagnosed CVD, diabetes, and cancer. During ten years of follow-up, we documented 1145 incident cases of fatal and non-fatal myocardial infarction (MI). After controlling for several known coronary risk factors, we observed a lower risk of coronary disease among men with use of vitamin E supplements. As compared with men who did not take vitamin E supplements, men who took at least 100 IU per day for at least two years had a multivariate relative risk of MI of 0.78 (95 percent confidence interval, 0.65 to 0.95). The benefits of vitamin E were substantially greater among populations free of CVD-related conditions. Among men without self-reported physician-diagnosed hypercholesterolmia, the RR of MI for vitamin E was 0.74 (95% CI 0.60,0.93). Men with hypercholesterolemia did not show appreciable benefit from vitamin E (RR=0.93;95% CI 0.63, 1.37). Men without hypertension had a lower risk of MI associated with vitamin E use (RR=0.74;95% CI 0.58, 0.94) than men with hypertension (RR=0.88;95% CI0.63, 1.22). Men free of either condition showed a significantly greater benefit from taking vitamin E (RR=0.71; 95% CI 0.54, 0.92) than men with either of these two conditions (RR=0.88; 0.67, 1.17). These data suggest a reduced risk of CHD for long term vitamin E supplement use among an otherwise healthy population and are consistent with the recent null findings from secondary prevention trials." @default.
• W4252006237 created "2022-05-12" @default.
• W4252006237 creator A5054114697 @default.
• W4252006237 date "2001-03-01" @default.
• W4252006237 modified "2023-09-28" @default.
• W4252006237 title "A Prospective Study of Vitamin E and Coronary Heart Disease Among Men:" @default.
• W4252006237 doi "https://doi.org/10.1161/circ.103.suppl_1.9999-16" @default.
• W4252006237 hasPublicationYear "2001" @default.
• W4252006237 type Work @default.
• W4252006237 citedByCount "0" @default.
• W4252006237 crossrefType "journal-article" @default.
• W4252006237 hasAuthorship W4252006237A5054114697 @default.
• W4252006237 hasBestOaLocation W42520062371 @default.
• W4252006237 hasConcept C124490489 @default.
• W4252006237 hasConcept C126322002 @default.
• W4252006237 hasConcept C134018914 @default.
• W4252006237 hasConcept C148759681 @default.
• W4252006237 hasConcept C185592680 @default.
• W4252006237 hasConcept C23131810 @default.
• W4252006237 hasConcept C2776940978 @default.
• W4252006237 hasConcept C2777551382 @default.
• W4252006237 hasConcept C2778004101 @default.
• W4252006237 hasConcept C2779134260 @default.
• W4252006237 hasConcept C44249647 @default.
• W4252006237 hasConcept C500558357 @default.
• W4252006237 hasConcept C55493867 @default.
• W4252006237 hasConcept C555293320 @default.
• W4252006237 hasConcept C71924100 @default.
• W4252006237 hasConcept C82789193 @default.
• W4252006237 hasConceptScore W4252006237C124490489 @default.
• W4252006237 hasConceptScore W4252006237C126322002 @default.
• W4252006237 hasConceptScore W4252006237C134018914 @default.
• W4252006237 hasConceptScore W4252006237C148759681 @default.
• W4252006237 hasConceptScore W4252006237C185592680 @default.
• W4252006237 hasConceptScore W4252006237C23131810 @default.
• W4252006237 hasConceptScore W4252006237C2776940978 @default.
• W4252006237 hasConceptScore W4252006237C2777551382 @default.
• W4252006237 hasConceptScore W4252006237C2778004101 @default.
• W4252006237 hasConceptScore W4252006237C2779134260 @default.
• W4252006237 hasConceptScore W4252006237C44249647 @default.
• W4252006237 hasConceptScore W4252006237C500558357 @default.
• W4252006237 hasConceptScore W4252006237C55493867 @default.
• W4252006237 hasConceptScore W4252006237C555293320 @default.
• W4252006237 hasConceptScore W4252006237C71924100 @default.
• W4252006237 hasConceptScore W4252006237C82789193 @default.
• W4252006237 hasIssue "suppl_1" @default.
• W4252006237 hasLocation W42520062371 @default.
• W4252006237 hasOpenAccess W4252006237 @default.
• W4252006237 hasPrimaryLocation W42520062371 @default.
• W4252006237 hasRelatedWork W2092224881 @default.
• W4252006237 hasRelatedWork W2139500584 @default.
• W4252006237 hasRelatedWork W2577067445 @default.
• W4252006237 hasRelatedWork W2799747446 @default.
• W4252006237 hasRelatedWork W2886454030 @default.
• W4252006237 hasRelatedWork W2895997049 @default.
• W4252006237 hasRelatedWork W2953466201 @default.
• W4252006237 hasRelatedWork W2993891568 @default.
• W4252006237 hasRelatedWork W3109537979 @default.
• W4252006237 hasRelatedWork W4327681630 @default.
• W4252006237 hasVolume "103" @default.
• W4252006237 isParatext "false" @default.
• W4252006237 isRetracted "false" @default.
• W4252006237 workType "article" @default.